000 | 01535 a2200445 4500 | ||
---|---|---|---|
005 | 20250518002037.0 | ||
264 | 0 | _c20181023 | |
008 | 201810s 0 0 eng d | ||
022 | _a1536-5964 | ||
024 | 7 |
_a10.1097/MD.0000000000012518 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDejust, Sebastien | |
245 | 0 | 0 |
_aEverolimus-induced pulmonary toxicity: Findings on 18F-FDG PET/CT imaging. _h[electronic resource] |
260 |
_bMedicine _cOct 2018 |
||
300 |
_ae12518 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Observational Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAndrostadienes _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aEverolimus _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorodeoxyglucose F18 |
650 | 0 | 4 |
_aGlycolysis _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Diseases, Interstitial _xchemically induced |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPositron Emission Tomography Computed Tomography |
650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aTumor Burden |
700 | 1 | _aMorland, David | |
700 | 1 | _aBruna-Muraille, Claire | |
700 | 1 | _aEymard, Jean-Christophe | |
700 | 1 | _aYazbek, Gabriel | |
700 | 1 | _aSavoye, Aude-Marie | |
700 | 1 | _aPapathanassiou, Dimitri | |
773 | 0 |
_tMedicine _gvol. 97 _gno. 40 _gp. e12518 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/MD.0000000000012518 _zAvailable from publisher's website |
999 |
_c28909140 _d28909140 |